2005
DOI: 10.1007/s10156-004-0366-7
|View full text |Cite
|
Sign up to set email alerts
|

Clinical utility of lipoarabinomannan antibody in pleural fluid for the diagnosis of tuberculous pleurisy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
5
0
2

Year Published

2005
2005
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 5 publications
0
5
0
2
Order By: Relevance
“…Anti-P32 levels were reported to be higher among five patients with pleural TB, but the sensitivity and specificity were not reported [43]. Sensitivity to anti-lipoarabinomannan (LAM) and to anti-TB glycolipid antibodies was very low in other studies, although specificity was high [44][45][46][47].…”
Section: B-cell Response (Antibody Detection)mentioning
confidence: 99%
“…Anti-P32 levels were reported to be higher among five patients with pleural TB, but the sensitivity and specificity were not reported [43]. Sensitivity to anti-lipoarabinomannan (LAM) and to anti-TB glycolipid antibodies was very low in other studies, although specificity was high [44][45][46][47].…”
Section: B-cell Response (Antibody Detection)mentioning
confidence: 99%
“…На предметные стекла наносили по 25 мкл полученной клеточной суспензии и инкубировали в течение 40 мин при комнатной температуре во влажной камере. Осевшие клетки фиксировали в течение 8-10 мин в холодном ацетоне, после чего наносили на стекла по 15 чего отмывали раствором Хэнкса из расчета 1 мл раствора на одну пробу. Подсчет флюоресцирующих клеток проводили на люминесцентном микроскопе («Micros», Австрия) предварительно добавляя 15 мкл глицероля.…”
Section: материалы и методыunclassified
“…In the earlier published studies, several non-bacteriological diagnostic parameters have been evaluated for the early laboratory diagnosis of TPE. These include (a) histopathology in pleural biopsy (Diacon et al, 2002), (b) nucleic acid amplification assay (Dinnes et al, 2007;Trajman et al, 2007), (c) estimation of biomarkers such as adenosine deaminase (Chen et al, 2004;Trajman et al, 2007), (d) antibody to mycobacterial glycolipids (Morimoto et al, 2006), (e) lipoarabinomannan (Yokoyama et al, 2005) and (f) IFN-γ (Greco et al, 2003;Jiang et al, 2007). These above diagnostic approaches do hold promise, but the sensitivities and specificities reported in these studies are highly variable and hence restricted the routine application as a diagnostic tool in patients with TPE.…”
Section: Introductionmentioning
confidence: 99%